Market Overview

UPDATE: Stifel Nicolaus Raises PT to $35 on Team Health Holdings on EPS Visibility

Share:
Related TMH
Earnings Scheduled For May 9, 2016
JP Morgan Downgrades Team Health To Neutral Amid Recent Upside

Stifel Nicolaus reiterated its Buy rating on Team Health Holdings (NYSE: TMH) and the price target from $30.00 to $35.00.

Stifel Nicolaus said, "The flu epidemic has made this the most active flu season in the U.S. since the H1N1 pandemic in the fall of 2009. Our analysis of (admittedly limited) historical data indicates a strong correlation between year-over-year changes in flu activity and Team's same-store volumes. This suggests upside to at least fourth quarter 2012 earnings. Given a favorable operating and acquisition environment, and the positive impact of Medicaid Parity on 2013 and 2014 earnings, we are raising our target price from $30 to $35."

Team Health Holdings closed at $31.89 on Friday.

Latest Ratings for TMH

DateFirmActionFromTo
Mar 2016Stifel NicolausMaintainsBuy
Mar 2016JP MorganDowngradesOverweightNeutral
Mar 2016JefferiesDowngradesBuyHold

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (TMH)

View Comments and Join the Discussion!